 - To evaluate the efficacy of allogeneic hematopoietic cell transplantation HCT in patients with acute lymphoblastic leukemia ALL in the first or second complete remission CR. The efficacy of the treatment will be measured in terms of the frequency of relapse and duration of remission the primary endpoints. 